Skip to content
healthcare.dev

Flower Antigens

NDC 44911-0324, Arsenicum Album, Lycopodium Clavatum, Pulsatilla (Pratensis), Bellis Perennis, Calendula Officinalis, Camellia Japonica, Chrysanthemum Coronarium, Chrysanthemum Leucanthemum, Convallaria Majalis, Gardenia Jasminoides, Impatiens Glandulifera, Flos, Iris Tenax, Lilium Tigrinum, Narcissus Pseudo-Narcissus, Rosa Damascena, Syringa Vulgaris, liquid, from Energique, Inc..

Product NDC
44911-0324
Status
Listed
Labeler
Energique, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0324 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARSENIC TRIOXIDE12 [hp_X]/mL
  • LYCOPODIUM CLAVATUM SPORE12 [hp_X]/mL
  • PULSATILLA PRATENSIS WHOLE12 [hp_X]/mL
  • BELLIS PERENNIS WHOLE12 [hp_C]/mL
  • CALENDULA OFFICINALIS FLOWERING TOP12 [hp_C]/mL
  • CAMELLIA JAPONICA FLOWER12 [hp_C]/mL
  • GLEBIONIS CORONARIA WHOLE12 [hp_C]/mL
  • LEUCANTHEMUM VULGARE WHOLE12 [hp_C]/mL
  • CONVALLARIA MAJALIS12 [hp_C]/mL
  • GARDENIA JASMINOIDES FLOWER12 [hp_C]/mL
  • IMPATIENS GLANDULIFERA FLOWER12 [hp_C]/mL
  • IRIS TENAX WHOLE12 [hp_C]/mL
  • LILIUM LANCIFOLIUM WHOLE FLOWERING12 [hp_C]/mL
  • NARCISSUS PSEUDONARCISSUS FLOWER12 [hp_C]/mL
  • ROSA DAMASCENA FLOWERING TOP12 [hp_C]/mL
  • SYRINGA VULGARIS FLOWER12 [hp_C]/mL
Package NDCNDC-11Package
44911-0324-14491103240130 mL in 1 BOTTLE, DROPPER (44911-0324-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 44911-0324 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0324 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44911-0324. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.